Xiaolei Wang

机构：Central Hospital of Zibo, Shandong First Medical University · ORCID：0000-0002-6950-4309

发表论文 53 篇 · 总被引 1700 次 · h-index 21

代表论文

• Novel advances in inhibiting advanced glycation end product formation using natural compounds (2021 · Biomedicine & Pharmacotherapy · 被引 258)
• High expression of RRM2 as an independent predictive factor of poor prognosis in patients with lung adenocarcinoma (2020 · Aging · 被引 146)
• Relationship between biofilm formation and antibiotic resistance of Klebsiella pneumoniae and updates on antibiofilm therapeutic strategies (2024 · Frontiers in Cellular and Infection Microbiology · 被引 77)
• Function and therapeutic prospects of next-generation probiotic Akkermansia muciniphila in infectious diseases (2024 · Frontiers in Microbiology · 被引 39)
• Adipose-derived stem cells alleviate liver injury induced by type 1 diabetes mellitus by inhibiting mitochondrial stress and attenuating inflammation (2022 · Stem Cell Research & Therapy · 被引 29)
• Allicin ameliorates glucose and lipid metabolism via modulation of gut microbiota and bile acid profile in diabetic rats (2023 · Journal of Functional Foods · 被引 21)